Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
WBA 
Walgreens Boots Alliance Inc (WBA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: WBA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -38.18% | Avg. Invested days 17 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.60B USD | Price to earnings Ratio - | 1Y Target Price 12.29 |
Price to earnings Ratio - | 1Y Target Price 12.29 | ||
Volume (30-day avg) 24577620 | Beta 0.6 | 52 Weeks Range 7.98 - 20.32 | Updated Date 03/27/2025 |
52 Weeks Range 7.98 - 20.32 | Updated Date 03/27/2025 | ||
Dividends yield (FY) 9.01% | Basic EPS (TTM) -10.24 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-26 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin -5.87% | Operating Margin (TTM) -0.13% |
Management Effectiveness
Return on Assets (TTM) 0.55% | Return on Equity (TTM) -80.85% |
Valuation
Trailing PE - | Forward PE 7.18 | Enterprise Value 39115560864 | Price to Sales(TTM) 0.06 |
Enterprise Value 39115560864 | Price to Sales(TTM) 0.06 | ||
Enterprise Value to Revenue 0.26 | Enterprise Value to EBITDA -22.57 | Shares Outstanding 864734976 | Shares Floating 714542578 |
Shares Outstanding 864734976 | Shares Floating 714542578 | ||
Percent Insiders 17.47 | Percent Institutions 63.52 |
Analyst Ratings
Rating 3 | Target Price 10.97 | Buy 1 | Strong Buy 2 |
Buy 1 | Strong Buy 2 | ||
Hold 12 | Sell 1 | Strong Sell 2 | |
Strong Sell 2 |
Upturn AI SWOT
Walgreens Boots Alliance Inc
Company Overview
History and Background
Walgreens Boots Alliance Inc. (WBA) traces its roots back to 1901 when Charles Walgreen Sr. purchased the drugstore in Chicago. It evolved through expansions, acquisitions, and mergers, including the significant merger with Alliance Boots in 2014, forming the present-day WBA.
Core Business Areas
- U.S. Retail Pharmacy: This segment includes Walgreens and Duane Reade pharmacies across the United States, providing prescription services, health and wellness products, and retail goods.
- International: This segment operates retail pharmacies and wholesale businesses outside the United States, primarily in Europe and Latin America.
- Healthcare: This segment provides innovative healthcare solutions and patient care across a variety of settings.
Leadership and Structure
The leadership team includes the CEO, CFO, and other key executives. The organizational structure consists of business segments and corporate functions, with oversight from the board of directors.
Top Products and Market Share
Key Offerings
- Prescription Medications: Dispensing prescription medications forms a significant part of WBA's revenue. Market share fluctuates but is a major player. Competitors include CVS, Rite Aid, and independent pharmacies. Revenue is significant, but is often bundled within segment reporting, making precise individual product revenue unclear.
- Health and Wellness Products: Includes over-the-counter medications, vitamins, supplements, and personal care items. WBA holds a substantial share of the OTC market. Competitors include CVS, Target, Walmart, and Amazon.
- Retail Goods: Includes general merchandise, beauty products, and convenience items sold in Walgreens and Duane Reade stores. The market share is diverse and depends on the specific product category. Competitors include CVS, supermarkets, and mass merchants.
Market Dynamics
Industry Overview
The retail pharmacy industry is facing pressure from online competition, reimbursement challenges, and increasing consolidation. The global retail pharmacy market is expanding, with significant growth observed in healthcare services beyond medication dispensing.
Positioning
WBA is positioned as a leading pharmacy chain focused on providing convenient access to prescriptions, health and wellness products, and healthcare services. Competitive advantages include its large store network, brand recognition, and pharmacy benefit management capabilities.
Total Addressable Market (TAM)
The global retail pharmacy market is estimated at hundreds of billions of dollars. WBA aims to capture a significant share of this TAM through its retail pharmacy business and expansion into health services.
Upturn SWOT Analysis
Strengths
- Large store network
- Strong brand recognition
- Integrated pharmacy benefit management (PBM) capabilities
- Established international presence
Weaknesses
- Exposure to reimbursement pressures
- High debt levels
- Dependence on retail pharmacy segment
- Inconsistent financial performance
Opportunities
- Expanding healthcare services
- Growing aging population
- Increasing demand for specialty medications
- Expanding digital presence
Threats
- Increased competition from online pharmacies
- Changes in healthcare regulations
- Reimbursement rate cuts
- Economic downturn
Competitors and Market Share
Key Competitors
- CVS
- RAD
- AMZN
Competitive Landscape
WBA competes with other pharmacy chains, online retailers, and healthcare providers. Its competitive advantages include its large store network and integrated PBM capabilities. Disadvantages include its high debt levels and exposure to reimbursement pressures.
Major Acquisitions
Shields Health Solutions
- Year: 2021
- Acquisition Price (USD millions): 1370
- Strategic Rationale: Acquiring full ownership of Shields Health Solutions to expand specialty pharmacy services and strengthen its healthcare capabilities.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been inconsistent, with fluctuations in revenue and earnings. Factors affecting growth include acquisitions, divestitures, and macroeconomic conditions.
Future Projections: Analyst estimates suggest potential for revenue growth driven by expansion into healthcare services and growth in international markets. Specific projections vary among analysts.
Recent Initiatives: Recent initiatives include expanding healthcare services, focusing on digital transformation, and streamlining operations.
Summary
Walgreens Boots Alliance faces both strengths and weaknesses. Its large network and brand provide stability, but debt and competitive pressures challenge growth. Expansion into healthcare services and effective digital strategies are key to future success. Monitoring reimbursement changes and online competition is crucial.
Similar Companies
- CVS
- RAD
- CI
- UNH
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Industry Reports
- Analyst Estimates
- Press Releases
Disclaimers:
This analysis is based on publicly available information and general industry knowledge. It should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Walgreens Boots Alliance Inc
Exchange NASDAQ | Headquaters Deerfield, IL, United States | ||
IPO Launch date 1985-07-01 | CEO & Director Mr. Timothy C. Wentworth | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 193000 | |
Full time employees 193000 | |||
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.